Related Experiment Video
Updated: Jan 25, 2026

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
Published on: October 31, 2025
IgG from anti-MDA5⁺ CADM patients impairs NK cell function via CD16 in RP-ILD
Yiying Yang1, Ke Liu2, Muyuan Li2
1Department of Rheumatology and Immunology, Xiangya Hospital, Department of Pathophysiology, Xiangya School of Basic Medicine Science, Central South University, Changsha, Hunan, China; Sepsis Translational Medicine Key Lab of Hunan Province, Changsha, Hunan, China; Postdoctoral Research Station of Biology, Xiangya School of Basic Medicine Science, Central South University, Changsha, Hunan, China.
Objective:
To investigate natural killer (NK) cell dysfunction in anti-MDA5 autoantibody-positive (anti-MDA5⁺) clinically amyopathic dermatomyositis (CADM) patients with rapidly progressive interstitial lung disease (RP-ILD), and explore potential mechanisms related to macrophage activation.
Methods:
Differentially expressed genes (DEGs) in peripheral blood mononuclear cells (PBMCs) from anti-MDA5+ CADM and anti-Jo1-positive (anti-Jo-1+) dermatomyositis patients were profiled using the Illumina HT-12 v4 chip. Cytokine profiles were analyzed using ELISA, and flow cytometry was performed to assess PBMC subsets, NK cell cytotoxicity, and the activation of PLC-γ2 and MAPK signaling. IgG purified from patient serum was used to assess antibody-dependent cellular cytotoxicity (ADCC) and phagocytosis (ADCP) in THP-1/THP-1-like macrophages under poly(I:C) stimulation.
Results:
Anti-MDA5⁺ CADM patients exhibited downregulated expression of NK cell activation receptor genes and elevated cytokines such as sCD163 and ferritin compared to anti-Jo-1⁺ patients. NK cell percentages in PBMCs were prominently decreased in anti-MDA5+ patients with RP-ILD compared to those without, and NK cell cytotoxicity or degranulation was weakened, as shown by decreased CD107a and perforin expression, while monocyte populations were increased in RP-ILD patients. IgG purified from anti-MDA5⁺ patient serum impaired NK-cell degranulation in vitro and enhanced ADCC/ADCP activity of THP-1 macrophages following poly(I:C) stimulation. These effects were reduced by CD16 knockdown, indicating involvement of FcγRIII (CD16) dependent interactions. PBMCs from RP-ILD patients exhibited hypophosphorylation of PLCγ2 and ERK, along with hyperphosphorylation of p38, consistent with altered downstream signaling associated with CD16 engagement.
Conclusion:
NK-cell dysfunction and enhanced macrophage activation in anti-MDA5⁺ CADM patients with RP-ILD are associated with dysregulated CD16-dependent IgG-cell interactions and perturbations in downstream PLCγ2-MAPK signaling. These findings highlight FcγR-mediated immune dysregulation as a potential contributor to the severe inflammatory phenotype characteristic of RP-ILD, while not establishing antigen-specific mechanisms.
Related Concept Videos
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

